# Ketamine for OUD and Suicidal Ideation in the ED

> **NCT06111339** · PHASE2 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 4 (actual)

## Conditions studied

- Opioid Use Disorder
- Suicidal Ideation

## Interventions

- **DRUG:** Ketamine
- **OTHER:** Saline Solution

## Key facts

- **NCT ID:** NCT06111339
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-06-14
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-03-31
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low recruitment numbers and study funding will be closing shortly.
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111339, "Ketamine for OUD and Suicidal Ideation in the ED". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06111339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*